CRISPR Therapeutics AG Total Assets 2015-2025 | CRSP

CRISPR Therapeutics AG total assets for the quarter ending March 31, 2025 were $2.166B, a 11.19% decline year-over-year.

  • CRISPR Therapeutics AG total assets for 2024 were $2.242B, a 0.56% increase from 2023.
  • CRISPR Therapeutics AG total assets for 2023 were $2.23B, a 0.6% decline from 2022.
  • CRISPR Therapeutics AG total assets for 2022 were $2.243B, a 18.49% decline from 2021.

CRISPR Therapeutics AG Total Assets 2015-2025 | CRSP

  • CRISPR Therapeutics AG total assets for 2024 were $2.242B, a 0.56% increase from 2023.
  • CRISPR Therapeutics AG total assets for 2023 were $2.23B, a 0.6% decline from 2022.
  • CRISPR Therapeutics AG total assets for 2022 were $2.243B, a 18.49% decline from 2021.